Skip to Content
Merck

1.41517

SAFC

PARTECK® COAT (Polyvinyl alcohol)

EMPROVE® ESSENTIAL, Ph. Eur., ChP, JPE, USP

Pharma Manufacturing

Synonym(s):

Parteck® Polyvinyl alcohol, PVA, PVOH

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
(C2H4O)n
CAS Number:
MDL number:
UNSPSC Code:
13111042

Agency

ChP
JPE
Ph. Eur.
USP

Quality Level

product line

EMPROVE® ESSENTIAL

form

fine powder

particle size

180-260 μm (d50)

mp

160-240 °C

application(s)

pharmaceutical
solid formulation

shipped in

ambient

storage temp.

15-25°C

InChI

1S/C2H4O/c1-2-3/h2-3H,1H2

InChI key

IMROMDMJAWUWLK-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

General description

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

Application

Parteck® COAT excipient is a particle-engineered polyvinyl alcohol (PVA) with a unique structure specifically designed for immediate release film coating application. Due to its optimized particle size, it helps to reduce dissolving times when preparing the coating solution, thus increasing process efficiency. Parteck® COAT excipient can be combined with a variety of supporting excipients such as plasticizers, anti-tacking agents and pigments – all available in our portfolio – to give you full flexibility in designing just the right coating for your need, and in the right timeframe. It is also very well-suited for coating ODT formulations using the Parteck® ODT orally disintegrating excipient system.

Features and Benefits

  • Excellent surface finishing - improve the appearance of your formulation
  • Rapid preparation of coating liquids even at room temperature
  • Low viscosity of coating liquids at high polymer concentration – enables reduced process times and enhanced efficiency
  • Stable moisture and oxygen barrier - effective protection of moisture-sensitive APIs

Legal Information

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 1


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

Related Content

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service